xtr006
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2022 (NCT06151808)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Microtubule-associated protein tauRadiopharmaceutical
MAPT radiopharmaceutical
Chemistry & pharmacology
- Imaging
- unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07115238 | Phase 3 | Nov 20, 2024 | Sinotau Pharmaceutical Group, University of Science and Technology of China |
| NCT06151808 | N/A | Sep 1, 2022 | People's Liberation Army of China, Sinotau Pharmaceutical Group |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinotau Pharmaceutical Group | Academic/Hospital | 2 | 2 | 2 | 2022 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2022 |
| University of Science and Technology of China | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1